Marketing-authorisation holder · United States
Corepharma
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMLODIPINE BESYLATE10mg base | 2.5mg base | 5mg base · Tablet | Amlodipine | United States | Marketed | 2005 |
| DECLOMYCIN150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Demeclocycline | United States | Not marketed | 1964 |
| DICYCLOMINE HYDROCHLORIDE10mg · Capsule | Dicycloverine | United States | Marketed | 1974 |
| DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE10mg | 15mg | 20mg | 25mg | 30mg | 5mg · Capsule, extended release | Dextroamphetamine saccharate, Amphetamine aspartate, Dexamfetamine, Amfetamine | United States | tentative | 2016 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|